FUJI PHARMA CO., LTD.

Press Releases Fuji Pharma Co., Ltd.

Equities

4554

JP3816200004

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-15 EDT			5-day change	1st Jan Change
1,529 ^JPY	+0.72%		-4.56%	-12.08%

2023	Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump	MT
2023	Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License to Develop and Commercialize Vistagen's Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan	23-09-06	AQ
Alvotech and Fuji Pharma Expand Partnership Adding a New Biosimilar Candidate	23-01-13	AQ
Mithra and Fuji announce approval of NEXTSTELLIS in Thailand	22-10-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW